Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?
about
Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitorsAdamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Zuogui Jiangtang Jieyu Formulation Prevents Hyperglycaemia and Depressive-Like Behaviour in Rats by Reducing the Glucocorticoid Level in Plasma and Hippocampus.Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins.A novel NADP(+)-dependent dehydrogenase activity for 7alpha/beta- and 11beta-hydroxysteroids in human liver nuclei: A third 11beta-hydroxysteroid dehydrogenase.Pharmacokinetic-pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects.Synthesis, in Vitro Covalent Binding Evaluation, and Metabolism of (14)C-Labeled Inhibitors of 11β-HSD1.Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
P2860
Q35207855-C53AEC5F-B63A-480E-B4E8-8B2E5017DD22Q35231710-3DC43D22-C91D-40E4-9ED4-FCC8628921ADQ35932257-4A8E3271-0879-4B47-A6F6-835600DF9CF8Q36434907-F7569525-721E-4C84-BCC6-5D471A053993Q36694003-F8337A42-6578-428A-B3C8-232F467B386DQ36969182-7A9BEAAB-D68A-4F6C-B80A-EB0683F771D1Q37344150-693AEFD8-B973-4F69-90A9-CB689E32E371Q37353444-913EF79A-0F5C-4503-958E-7BF53BE8B9BFQ41975049-68B0CC35-75F7-43BE-B7B8-103FEE152F89Q51380849-BE4D7456-D688-47A9-86EA-60B0C591A5ACQ51468764-093A4F30-AC85-44F6-9B00-D28D86AC18C5
P2860
Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@ast
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@en
type
label
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@ast
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@en
prefLabel
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@ast
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@en
P2860
P356
P1476
Inhibition of 11beta-HSD1 as a ...... o glucocorticoids play a role?
@en
P2093
Anne Hermanowski-Vosatka
Rolf Thieringer
P2860
P304
P356
10.1586/14779072.3.5.911
P577
2005-09-01T00:00:00Z